The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial
EMPAgliflozin 对同时患有 2 型糖尿病和冠状动脉疾病的患者炎症标志物的影响：EMPA-CARD 随机对照试验
期刊:Diabetology & Metabolic Syndrome
影响因子:3.4
doi:10.1186/s13098-022-00951-5
Sepehr Gohari #, Tara Reshadmanesh #, Hadi Khodabandehloo, Amir Karbalaee-Hasani, Hassan Ahangar, Shahram Arsang-Jang, Faramarz Ismail-Beigi, Mohsen Dadashi, Samin Ghanbari, Homa Taheri, Mojtaba Fathi, Muhammad Javad Muhammadi, Reyhaneh Mahmoodian, Atieh Asgari, Mohammadreza Tayaranian, Mehdi Moharr
